Navigation Links
Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or 'Off-The-Shelf' Stem Cell Treatment for Heart Attacks
Date:9/5/2011

MELBOURNE, Australia, Sept. 5, 2011 /PRNewswire/ -- Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor(TM) is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction).

The placebo-controlled Phase 2 trial, AMICI (Allogeneic Mesenchymal precursor cell Infusion in myoCardial Infarction), is approved under Europe's voluntary harmonization procedure and will initially recruit patients at multiple European sites, including in the United Kingdom, The Netherlands and Belgium. Trial recruitment is subsequently expected to involve sites in additional European nations, Australia, and the United States. The primary endpoint of the study will be safety and efficacy at six months in heart attack patients who will receive either Revascor(TM) at one of two doses or placebo. Durability of effect will additionally be monitored for up to 36 months.

Heart attacks remain the biggest killer of people in the industrialized world. Every year, over 1.7 million people have a heart attack in Europe, and over 1.1 million in the United States. Most of these patients undergo an early angioplasty of the blocked artery accompanied by implantation of a metal stent to keep the artery open long-term. However, a significant number of the surviving patients subsequently become disabled with heart failure.

Revascor(TM) is injected by a simple intracoronary infusion at the same time as the
'/>"/>

SOURCE Mesoblast
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lupin Receives Final Approval to Market Generic Ultram® ER
2. Assured Pharmacy, Inc. Receives Gross Proceeds of $400,000 from Sale of Convertible Debentures and Warrants
3. Masimo Pronto-7™ Receives Japanese and Canadian Regulatory Clearances
4. Linagliptin Receives Approval in Europe for the Treatment of Type 2 Diabetes
5. Simceres Iremod Receives SFDA New Drug Approval
6. PSI-938 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
7. WuXi AppTec Bioanalytical Services Unit Receives GLP Certificate from OECD and EU
8. Abbott Receives CE Mark for Healon EndoCoat Protective Gel for Cataract Surgery
9. CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
10. Inhibikase Therapeutics Receives FDA Clearance for Phase II Trial of IkT-001 to Treat JC Virus Infection, the Cause of Progressive Multifocal Leukoencephalopathy (PML) in Multiple Sclerosis Patients
11. INNOPHARMA Receives FDA Approval of Generic Levetiracetam Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015  BioSpecifics Technologies Corp. ... in class collagenase-based products marketed as XIAFLEX ® ... EU, announced today that BioSpecifics, President, Tom Wegman ... Jefferies 2015 Healthcare Conference.    The presentation ... 3:00 p.m. ET in New York, NY ...
(Date:5/26/2015)... Israel , May 26, 2015 /PRNewswire/ ... Dario™ Diabetes Management Solution, announced today that ... leading HMO, Maccabi Healthcare, it has ... as part of Maccabi,s advanced Telecare unit ... diabetes management solution that enables remote treatment ...
(Date:5/26/2015)... Minn. , May 26, 2015  MGC Diagnostics Corporation ... conference call to discuss its financial results for the second ... will be at 4:30 p.m. ET on Tuesday, June 2, ... quarter of fiscal 2015 at the close of the markets ... dial (877) 317-6789 or (412) 317-6789 to access the conference ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. to Present at the Jefferies 2015 Healthcare Conference 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 3LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 4MGC Diagnostics Corporation to Report Second Quarter Fiscal 2015 Financial Results on Tuesday, June 2, 2015 2
... and PARIS , July 19 Corgenix Medical Corporation ... kits, and the ELITech Group, a Paris, France -based, privately held ... and reagents, today announced a broad strategic alliance. Terms of the agreement ... ...
... , ZURICH , July 19, 2010 ... - an,observational study designed to investigate the effects of modern insulins in,the management of ... Spanning ... be the world,s largest observational study,in insulin therapy. , ...
Cached Medicine Technology:Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 2Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 3Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 4World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 2World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 3
(Date:5/26/2015)... It was an evening befitting the largest, ... Wednesday, May 13, The Denver Foundation marked 90 years ... community-based giving with its Annual Celebration, held at the ... the event celebrated the donors, leaders, grantees, and volunteers ... for good. , “If your organization, neighborhood group, or ...
(Date:5/26/2015)... 2015 Relias Learning , the ... health and human services market, announces expansion of their ... strong attendance and participation in 2014, they will double ... annual user conference an exciting new facelift. , ... together and discuss best practices, share their expertise, provide ...
(Date:5/26/2015)... 26, 2015 CIO Review has chosen ... Pharma and Life Sciences Technology Solution Providers. The positioning is ... compliant solution which is applicable across the entire security spectrum ... for broad adoption. , “SIGNiX has been on our ... Pharma and Life Sciences Technology space, and we are happy ...
(Date:5/26/2015)... Fredericton, New Brunswick (PRWEB) May 26, 2015 ... , announce the successful upgrade of the DMi ... software. This version was the first in Indosoft's contact ... included API improvements, added screen support for such trunk ... admin screens, improved lead management, and included upgrades to ...
(Date:5/26/2015)... York, USA (PRWEB) May 26, 2015 ... the site, AnyTranscription has undertaken a comprehensive upgrade of ... improvement in user experience. To thank users for their ... launching this five minute trial transcription service ... weeks from May 26 to June 9 this year. ...
Breaking Medicine News(10 mins):Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 2Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 3Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 3
... how neurons communicate with one another, and could affect how ... the current issue of Neuron , was authored by ... Toronto Scarborough (UTSC), and colleagues at MIT and Duke University. ... of zinc in the brain for more than fifty years, ...
... first seven days after a severe head injury results in ... State College of Medicine researchers. This is especially true for ... to the hospital. A tracheostomy is an opening created ... to allow unimpeded breathing. (A tracheotomy is the act of ...
... study recently published in European Physical Journal E ... how to best avoid jamming of soft matter that can ... Voigtmann, a researcher at the Institute for Material Physics in ... yield stress, to be overcome before a solid material made ...
... games, already known to improve motor function in,recovering stroke ... intensive care units (ICU), new research from Johns,Hopkins suggests. ... Journal of Critical Care ,researchers studied the safety and ... in the ICU. "Patients admitted to our medical ...
... new study from the University of Adelaide shows the parents of ... some form of cardiovascular disease. PCOS is a hormonal disorder ... one of the most common endocrine disorders in women and a ... with PCOS are more likely to have any form of cardiovascular ...
... Annual Osteoporosis Symposium, the announcement was made that Hologic, ... diagnosis of osteoporosis in Armenia. This brings the number ... to 5 over the past 4 years. Dual-energy X-ray ... the technologies used to measure bone mineral density (BMD). ...
Cached Medicine News:Health News:Earlier tracheostomies result in better patient outcomes 2Health News:Unlocking jams in fluid materials 2Health News:Practical play: Interactive video games appear valuable for ICU patients 2Health News:Capacity to diagnose osteoporosis doubles in Armenia 2Health News:Capacity to diagnose osteoporosis doubles in Armenia 3
... a highly sensitive DR system. It features ... it is designed for most general radiographic ... multiple wall stand and table configurations. , ... efficiently produces detailed patient images with reduced ...
... to remove bone cement speedily and efficiently. , ... cement at the point of contact, allowing it ... feature of the apparatus is its ability to ... to the operator instantly. Probe position can thus ...
Provides stable positioning of the knee during surgery....
... processes blood collected from a surgical ... cells for return to a patient ... achieved with only one kit and ... coupled with sophisticated software, provides an ...
Medicine Products: